Kayat, a Cypriot company, alleged that Genzyme breached an exclusive distribution agreement for the Former Soviet Union, resulting in damages in excess of $300 million. To support its claim, Kayat presented expert testimony on sales but for the alleged breach, and damages. On behalf of Genzyme, Mr. Chodorow provided expert testimony explaining key flaws in the methodology and implementation of the analyses conducted by the plaintiff’s experts that made their conclusions unreliable and overstated. The court agreed with these conclusions. The ruling found that Genzyme had breached the distribution agreement, but awarded Kayat only $7.6 million in damages.